Published in Cell on October 01, 1983
Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc Natl Acad Sci U S A (1985) 6.45
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol Cell Biol (1984) 5.79
Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol Cell Biol (1988) 3.96
The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci U S A (1984) 3.31
Expression and characterization of the human c-myc DNA-binding protein. Mol Cell Biol (1985) 3.24
Nucleotide sequence of the human N-myc gene. Proc Natl Acad Sci U S A (1986) 2.99
c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol (2000) 2.96
E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA. Mol Cell Biol (1985) 2.68
Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum. Mol Cell Biol (1987) 2.40
Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol (2013) 2.37
Human proto-oncogene N-myc encodes nuclear proteins that bind DNA. Mol Cell Biol (1986) 2.15
Myc oncoproteins are phosphorylated by casein kinase II. EMBO J (1989) 2.11
c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol Cell Biol (1988) 2.10
v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J Virol (1988) 2.08
Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol (1994) 2.01
Production of human c-myc protein in insect cells infected with a baculovirus expression vector. Mol Cell Biol (1985) 2.00
DNA sequences that mediate attenuation of transcription from the mouse protooncogene myc. Proc Natl Acad Sci U S A (1989) 1.94
Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5' untranslated region. Proc Natl Acad Sci U S A (1985) 1.94
Inducible overproduction of the mouse c-myc protein in mammalian cells. Proc Natl Acad Sci U S A (1986) 1.89
Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci (2007) 1.88
Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene. Mol Cell Biol (1985) 1.84
Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. Mol Cell Biol (1989) 1.84
Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity. Proc Natl Acad Sci U S A (1987) 1.82
Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing. Mol Cell Biol (1988) 1.78
Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma. Proc Natl Acad Sci U S A (1984) 1.76
Biological activities of v-myc and rearranged c-myc oncogenes in rat fibroblast cells in culture. Proc Natl Acad Sci U S A (1984) 1.72
Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol Cell Biol (1997) 1.69
Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc Natl Acad Sci U S A (1993) 1.65
A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Proc Natl Acad Sci U S A (2000) 1.61
Transformation of mammalian fibroblasts and macrophages in vitro by a murine retrovirus encoding an avian v-myc oncogene. EMBO J (1984) 1.55
The function of activity-regulated genes in the nervous system. Physiol Rev (2009) 1.54
An overview of MYC and its interactome. Cold Spring Harb Perspect Med (2014) 1.53
High-frequency disruption of the N-myc gene in embryonic stem and pre-B cell lines by homologous recombination. Mol Cell Biol (1990) 1.43
Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol (1986) 1.42
Expression of the c-myc proto-oncogene during development of Xenopus laevis. Mol Cell Biol (1986) 1.40
Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein. Mol Cell Biol (1994) 1.39
A first exon-encoded domain of E1A sufficient for posttranslational modification, nuclear-localization, and induction of adenovirus E3 promoter expression in Xenopus oocytes. Proc Natl Acad Sci U S A (1985) 1.36
Growth-dependent synthesis of c-myc-encoded proteins: early stimulation by serum factors in synchronized mouse 3T3 cells. Mol Cell Biol (1985) 1.34
Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells. Mol Cell Biol (1986) 1.32
Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J Cell Biol (1992) 1.32
Molecular cloning and regulated expression of the human c-myc gene in Escherichia coli and Saccharomyces cerevisiae: comparison of the protein products. Proc Natl Acad Sci U S A (1985) 1.31
Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol Cell Biol (1990) 1.27
Regulation of the human c-myc gene: 5' noncoding sequences do not affect translation. Mol Cell Biol (1985) 1.26
Nucleotide sequence of avian carcinoma virus MH2: two potential onc genes, one related to avian virus MC29 and the other related to murine sarcoma virus 3611. Proc Natl Acad Sci U S A (1984) 1.25
Production of simian virus 40 large tumor antigen in bacteria: altered DNA-binding specificity and dna-replication activity of underphosphorylated large tumor antigen. Proc Natl Acad Sci U S A (1989) 1.20
The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs. Mol Cell Biol (1988) 1.18
Nucleotide sequence of two overlapping myc-related genes in avian carcinoma virus OK10 and their relation to the myc genes of other viruses and the cell. Proc Natl Acad Sci U S A (1985) 1.16
The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. Mol Cell Biol (1995) 1.14
Differential expression of two Xenopus c-myc proto-oncogenes during development. EMBO J (1989) 1.11
myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts. Mol Cell Biol (1985) 1.11
Mutagenesis of avian carcinoma virus MH2: only one of two potential transforming genes (delta gag-myc) transforms fibroblasts. Proc Natl Acad Sci U S A (1985) 1.10
Translocation of a store of maternal cytoplasmic c-myc protein into nuclei during early development. Mol Cell Biol (1989) 1.10
Rapid induction of polyadenylated H1 histone mRNAs in mouse erythroleukemia cells is regulated by c-myc. Mol Cell Biol (1989) 1.08
Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. J Clin Invest (1986) 1.07
Myc: the beauty and the beast. Genes Cancer (2010) 1.07
Ultrastructural localization of a platelet-derived growth factor/v-sis-related protein(s) in cytoplasm and nucleus of simian sarcoma virus-transformed cells. Proc Natl Acad Sci U S A (1987) 1.06
Transformation of quail embryo fibroblasts by a retrovirus carrying a normal human c-myc gene. EMBO J (1986) 1.06
Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein. Mol Biol Cell (1994) 1.04
Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells. J Virol (1991) 1.03
Nucleotide sequence of a transduced myc gene from a defective feline leukemia provirus. J Virol (1985) 1.03
A genetic map of mouse chromosome 12 composed of polymorphic DNA fragments. J Exp Med (1984) 1.02
Immunochemical detection of proteins related to the human c-myc exon 1. EMBO J (1986) 1.00
Neoplastic transformation of rat 3Y1 cells by a transcriptionally activated human c-myc gene and stabilization of p53 cellular tumor antigen in the transformed cells. Mol Cell Biol (1986) 0.98
Inhibition of DNA binding of purified p55v-myc in vitro by antibodies against bacterially expressed myc protein and a synthetic peptide. EMBO J (1984) 0.98
A second c-myb protein is translated from an alternatively spliced mRNA expressed from normal and 5'-disrupted myb loci. Mol Cell Biol (1989) 0.98
Analysis of a deleted MC29 provirus: gag sequences are not required for fibroblast transformation. J Virol (1985) 0.97
The second oncogene mil of avian retrovirus MH2 is related to the src gene family. EMBO J (1984) 0.95
c-myc can induce expression of G0/G1 transition genes. Mol Cell Biol (1988) 0.95
Characterization of a myc-containing retrovirus generated by propagation of an MH2 viral subgenomic RNA. J Virol (1986) 0.95
Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene. Mol Cell Biol (1989) 0.94
Molecular cloning of proviral DNA and structural analysis of the transduced myc oncogene of avian oncovirus CMII. J Virol (1985) 0.93
Structure and transforming function of transduced mutant alleles of the chicken c-myc gene. J Virol (1986) 0.93
gag as well as myc sequences contribute to the transforming phenotype of the avian retrovirus FH3. J Virol (1992) 0.92
The interleukin-1 receptor in Raji human B-lymphoma cells. Molecular characterization and evidence for receptor-mediated activation of gene expression. Biochem J (1989) 0.91
Translocation of c-myc into the immunoglobulin heavy-chain locus in human acute B-cell leukemia. A molecular analysis. EMBO J (1986) 0.89
c-MYC-induced genomic instability. Cold Spring Harb Perspect Med (2014) 0.89
FH3, a v-myc avian retrovirus with limited transforming ability. J Virol (1989) 0.88
MYC cofactors: molecular switches controlling diverse biological outcomes. Cold Spring Harb Perspect Med (2014) 0.88
Mutations within the 5' half of the avian retrovirus MC29 v-myc gene alter or abolish transformation of chicken embryo fibroblasts and macrophages. J Virol (1992) 0.87
myc protooncogene linked to retroviral promoter, but not to enhancer, transforms embryo cells. Proc Natl Acad Sci U S A (1988) 0.87
Posttranslational regulation of Myc by promyelocytic leukemia zinc finger protein. Int J Cancer (2009) 0.87
Transforming variants of the avian myc-containing retrovirus FH3 arise prior to phenotypic selection. J Virol (1993) 0.87
The myc proteins are not associated with chromatin in mitotic cells. EMBO J (1984) 0.87
Multiple growth-associated nuclear proteins immunoprecipitated by antisera raised against human c-myc peptide antigens. Mol Cell Biol (1986) 0.86
Translocation and rearrangement of c-myc into immunoglobulin alpha heavy chain locus in primary cells from acute lymphocytic leukemia. Proc Natl Acad Sci U S A (1984) 0.85
Coordinate regulation of myelomonocytic phenotype by v-myb and v-myc. Mol Cell Biol (1986) 0.85
Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation. Mol Cell Biol (1993) 0.85
Temperature-sensitive mutants of MH2 avian leukemia virus that map in the v-mil and the v-myc oncogene respectively. EMBO J (1986) 0.85
Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesis. J Virol (1986) 0.83
Early synthesis of specific cytoplasm proteins is correlated with the rate of exit of lymphocytes from the resting state. J Cell Biol (1984) 0.81
Protein product of proto-oncogene c-mil. Mol Cell Biol (1986) 0.81
Retention or loss of v-mil sequences after propagation of MH2 virus in vivo or in vitro. J Virol (1987) 0.81
Isolation of an MH2 retrovirus mutant temperature sensitive for macrophage but not fibroblast transformation. J Virol (1986) 0.80
Two autonomous myc oncogenes in avian carcinoma virus OK10. J Virol (1988) 0.79
MC29 virus-coded protein occurs as monomers and dimers in transformed cells. J Virol (1985) 0.79
Detection of a Myc-associated protein by chemical cross-linking. Mol Cell Biol (1989) 0.79
Inhibitory effect of myristylation on transrepression by FBR (Gag-Fos) protein. Mol Cell Biol (1992) 0.77
An avian retrovirus expressing chicken pp59c-myc possesses weak transforming activity distinct from v-myc that may be modulated by adjacent normal cell neighbors. J Virol (1991) 0.77
c-myc protein distribution. Neoplastic tissues of the human colon. Am J Pathol (1992) 0.76
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (1991) 12.00
A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature (1997) 9.71
The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol (2000) 8.47
Sequence-specific DNA binding by the c-Myc protein. Science (1990) 7.75
Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell (1997) 7.64
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci U S A (2000) 6.30
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol Cell Biol (1984) 5.79
Drosophila myc regulates cellular growth during development. Cell (1999) 5.66
A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell (1988) 5.49
Adhesion plaques of Rous sarcoma virus-transformed cells contain the src gene product. Proc Natl Acad Sci U S A (1980) 5.42
Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell (1993) 5.28
Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell (1995) 4.98
Myc and Max proteins possess distinct transcriptional activities. Nature (1992) 4.16
Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol (1993) 4.08
c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature (1985) 3.72
A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev (1993) 3.60
New light on Myc and Myb. Part I. Myc. Genes Dev (1990) 3.57
Nuclear location of the putative transforming protein of avian myelocytomatosis virus. Cell (1982) 3.51
c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci U S A (1999) 3.48
Identification of a Rous sarcoma virus transformation-related protein in normal avian and mammalian cells. Proc Natl Acad Sci U S A (1979) 3.31
Sin meets NuRD and other tails of repression. Cell (1999) 3.31
Myc and Max associate in vivo. Genes Dev (1992) 3.16
Immunofluorescence on avian sarcoma virus-transformed cells: localization of the src gene product. Cell (1979) 3.06
c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol (2000) 2.96
Synthesis and processing of polymerase proteins of wild-type and mutant avian retroviruses. J Virol (1980) 2.92
V-myc- and c-myc-encoded proteins are associated with the nuclear matrix. Mol Cell Biol (1985) 2.86
Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J (1996) 2.86
p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev (1996) 2.77
A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev (1993) 2.65
Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature (1990) 2.65
SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors. Mol Cell (1998) 2.60
The biosynthesis of oncovirus proteins. Biochim Biophys Acta (1978) 2.57
New light on Myc and Myb. Part II. Myb. Genes Dev (1990) 2.57
Mad proteins contain a dominant transcription repression domain. Mol Cell Biol (1996) 2.52
Myc target genes. Trends Biochem Sci (1997) 2.34
Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene (1999) 2.34
Antibodies to a defined region of pp60src neutralize the tyrosine-specific kinase activity. J Biol Chem (1983) 2.33
Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol Cell (1998) 2.21
Myc oncoproteins are phosphorylated by casein kinase II. EMBO J (1989) 2.11
c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol Cell Biol (1988) 2.10
Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol (1994) 2.01
Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev (1997) 1.96
Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J (1995) 1.93
Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype. Cell (1988) 1.91
The NH2-terminal sequence of the avian oncovirus gag precursor polyprotein (Pr76gag). Virology (1978) 1.90
Myc and Max homologs in Drosophila. Science (1996) 1.85
Murine c-fms cDNA: cloning, sequence analysis and retroviral expression. Oncogene Res (1988) 1.79
Delineation of transcriptional control signals within the Moloney murine sarcoma virus long terminal repeat. Mol Cell Biol (1985) 1.77
Myc and Max function as a nucleoprotein complex. Curr Opin Genet Dev (1992) 1.76
Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev (1998) 1.74
The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol Cell Biol (2000) 1.71
Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol Cell Biol (1997) 1.69
A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Proc Natl Acad Sci U S A (2000) 1.61
Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol Cell Biol (1998) 1.61
A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol Cell Biol (1995) 1.59
Detection of the v-abl gene product at cell-substratum contact sites in Abelson murine leukemia virus-transformed fibroblasts. J Virol (1984) 1.57
Casein kinase II as a potentially important enzyme concerned with signal transduction. Cold Spring Harb Symp Quant Biol (1988) 1.57
Shc, Grb2, Sos1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells. Mol Cell Biol (1994) 1.56
Solution structure of the interacting domains of the Mad-Sin3 complex: implications for recruitment of a chromatin-modifying complex. Cell (2000) 1.51
The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II. New Biol (1989) 1.47
Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. EMBO J (1999) 1.45
Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene (1995) 1.41
Myc-mediated transformation: the repression connection. Oncogene (1999) 1.41
Expression of the c-myc proto-oncogene during development of Xenopus laevis. Mol Cell Biol (1986) 1.40
Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J (1998) 1.39
Biosynthesis and metabolism of viral proteins expressed on the surface of murine leukemia virus-infected cells. Virology (1978) 1.39
Macrophage colony-stimulating factor-induced tyrosine phosphorylation of c-fms proteins expressed in FDC-P1 and BALB/c 3T3 cells. Mol Cell Biol (1990) 1.38
The Smad transcriptional corepressor TGIF recruits mSin3. Cell Growth Differ (2001) 1.36
Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol Cell Biol (1996) 1.35
Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J Cell Biol (1992) 1.32
A role for the p34cdc2 kinase and phosphatases in the regulation of phosphorylation and disassembly of lamin B2 during the cell cycle. EMBO J (1991) 1.30
Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol Cell Biol (1990) 1.27
Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogene (1998) 1.27
Negative regulation of c-myc transcription involves myc family proteins. Oncogene Res (1988) 1.27
Common features of the yes and src gene products defined by peptide-specific antibodies. J Virol (1984) 1.26
Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis. J Biol Chem (1992) 1.23
Transformation by the v-fms oncogene product: role of glycosylational processing and cell surface expression. Mol Cell Biol (1985) 1.22
Early events in M-CSF receptor signaling. Growth Factors (2000) 1.20
Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. Am J Pathol (1990) 1.18
Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb protein binding by the E7 protein of human papillomavirus type 16. Proc Natl Acad Sci U S A (1991) 1.18
Mona, a novel hematopoietic-specific adaptor interacting with the macrophage colony-stimulating factor receptor, is implicated in monocyte/macrophage development. EMBO J (1998) 1.17
Transcriptional activities of the Myc and Max proteins in mammalian cells. Curr Top Microbiol Immunol (1992) 1.16
c-erbA encodes multiple proteins in chicken erythroid cells. Mol Cell Biol (1988) 1.16
The mammalian numb phosphotyrosine-binding domain. Characterization of binding specificity and identification of a novel PDZ domain-containing numb binding protein, LNX. J Biol Chem (1998) 1.15
Genomic binding and transcriptional regulation by the Drosophila Myc and Mnt transcription factors. Cold Spring Harb Symp Quant Biol (2005) 1.13
Expression of the M-CSF receptor is controlled posttranscriptionally by the dominant actions of GM-CSF or multi-CSF. Cell (1990) 1.13
Synthesis of the precursor to avian RNA tumor virus internal structural proteins early after infection. Virology (1976) 1.11
The stimulation of phospholipid metabolism in mouse skin following phorbol ester treatment. Biochim Biophys Acta (1972) 1.09
Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network. Biochim Biophys Acta (1999) 1.09
Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis. Mol Cell Biol (2001) 1.09
Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signaling. EMBO J (1997) 1.08